Yasar B, Chapman E, Taylor H, Parker C, et al. Predictors of long-term disease-free survival with stereotactic body radiotherapy for metachronous oligometastatic prostate cancer. Int J Radiat Oncol Biol Phys 2025 Nov 29:S0360-3016(25)06527.
PMID: 41325871